The most commonly identified rearrangement in NSCLC is the KIF5B-RET fusion [83,120,121], although other fusion partners such as CCDC6, NCOA4, TRIM33, and CUX1 have also been identified [122]. The gene discussed is RET; the disease is non-small cell lung carcinoma.